Zevra Therapeutics to Participate at Upcoming Investor Conferences in September

Core Viewpoint - Zevra Therapeutics, Inc. is actively engaging in upcoming industry events to showcase its commitment to developing therapies for rare diseases [1][2]. Company Overview - Zevra Therapeutics, Inc. is a commercial-stage company focused on creating transformational therapies for rare diseases that have limited or no treatment options [2]. - The company's mission is to provide life-changing therapeutics to individuals living with rare diseases, utilizing unique, data-driven development and commercialization strategies [2]. Upcoming Events - Zevra's executive leadership team will participate in the Cantor Global Healthcare Conference on September 3, 2025, at 11:30 a.m. ET [5]. - The company will also be present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 10:00 a.m. ET [5]. - Management will be available for one-on-one meetings with registered conference attendees, and live webcasts will be accessible on the Investor Relations section of Zevra's website [1].